ClinConnect ClinConnect Logo
Search / Trial NCT06708377

Dry Needling and Myofascial Massage Therapy on Patient With Temporomandibular Joint Dysfunction

Launched by RIPHAH INTERNATIONAL UNIVERSITY · Nov 26, 2024

Trial Information

Current as of November 13, 2025

Recruiting

Keywords

Tmj Dysfunction Dry Needling Myofascial Massage Therapy

ClinConnect Summary

This clinical trial is studying how two different treatments—dry needling and myofascial massage therapy—affect people with Temporomandibular Joint Dysfunction (TMJ). TMJ can cause pain and limited movement in the jaw, making it hard to open your mouth fully. The trial will take place over six months and will involve 24 participants aged between 25 and 45 who have specific symptoms, including reduced mouth opening and muscle pain in the jaw.

To be eligible for this study, participants must have TMJ dysfunction and be able to open their mouths less than a certain amount (39 mm for men and 36 mm for women). They should also experience mild to moderate pain and have a particular score on a TMJ-related questionnaire. Those who have certain conditions, have had jaw surgery, or are unable to consent will not be included. Participants can expect to have their pain and jaw movement evaluated at the beginning, after one week, and again after three weeks. This trial aims to find out which treatment may be more effective in helping people manage their TMJ symptoms.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Participants with TMJ dysfunction
  • A mouth opening of less than 39 mm for males and 36mm for females
  • Patients with Trigger points in tout band of masseter
  • Mild to moderate pain on NPRS
  • 45-75 points on Fonseca's questionnaire
  • Exclusion Criteria:
  • Bell's palsy
  • Trigeminal neuralgia
  • Wearing any form of dental prosthesis
  • Any form of surgery in or around the TMJ
  • History of trauma or fracture in and around the TMJ
  • Not consenting to take part in the study

About Riphah International University

Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.

Locations

Islamabad, Federal, Pakistan

Patients applied

0 patients applied

Trial Officials

Lal Gul Khan, MScPT

Principal Investigator

Riphah International University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported